NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I agree with your view. But recognizing that any time in the 2nd half of the year is a good time as well. Agencies are notoriously slow, MHRA is always complaining that it is still understaffed and this is a new technology and they are, while still seeming incredibly supportive, a careful agency.

Validation here will speak well to likely validation ultimately at all the other agencies and the market should take this validation as a profound validation. I can’t say that it will, given the market manipulation, but I think that would be the most logical and realistic interpretation of validation in the UK.